with lung cancer receive timely access to appropriate specialist care. Australian guidelines recommend that the first specialist appointment should take place within two weeks of the initial GP referral. However, local data indicate that up to 60% of patients are not referred within two weeks, while state-based data shows that 11% of patients in New South Wales (NSW), Australia, do not see a lung cancer specialist at all; these patients may be missing out on curative and palliative treatments. We designed a primary care intervention to address these gaps and conducted a feasibility study in three sites across NSW. The RoaDmaP pilot study aimed to develop, implement and evaluate the Referral Decision Prompt (RDP), an intervention that supports GPs to refer patients with a suspicious lung lesion on CT scan for specialist care. Specific objectives were to evaluate feasibility and acceptability with GPs, radiologists and radiology practice staff. Method: The RDP intervention was developed with key stakeholder input and was tailored for three participating radiology practices. Eligibility criteria included any patient aged over 18 attending for a chest CT scan.Recruitment and consent procedures were tested to enable collection of patient's medical data from GPs and hospitals to confirm lung cancer diagnoses. The RDP template was integrated into CT scan reports for patients with a suspicious lung lesion. A process evaluation with GPs, radiologists and radiology staff was undertaken through brief surveys and qualitative focus groups. Result: Over seven months, 445 patients had a GP-referred chest CT scan; 400 were given study documents; 293 consented (73%). Twelve patients had a suspicious lesion, eight of whom received a confirmed lung cancer diagnosis. Sixty-six percent had a specialist appointment within two weeks. The intervention was rated as highly acceptable by radiologists, radiographers and practice staff; four GPs participated in the evaluation, three recalled the RDP and two used it to change their referral practices. Conclusion: The RoaDmaP study presents an innovative approach to identifying lung cancer patients prior to diagnosis and has the potential to improve timely and appropriate specialist referral. The process evaluation findings indicate that this simple, low-cost intervention is feasible and can be easily integrated into radiology reporting practices. It is highly acceptable to radiologists and practice staff, and may positively influence GP referral practices.Background: Brain metastases frequently occur in patients with small-cell lung cancer. Therefore, prophylactic cranial irradiation (PCI) is recommended for good responders of initial treatment. The purpose of this study was to investigate influence of PCI on pattern of brain metastases as a first recurrence site (BMFR) after radical treatment for limited disease small-cell lung cancer (LD-SCLC). Method: This retrospective study included LD-SCLC patients treated with thoracic radiotherapy and concurrent chemotherapy between January 2006 and D...
Objectives: To describe the pattern of clavicle fractures and to evaluate the results of surgical treatment for clavicle fractures. Patients and methods: This retrospective study included 38 cases of clavicle fractures who were treated by open reduction internal fi xation at Hanoi Medical University Hospital between January 2008 and June 2013. Results: The ratio of male to female was 1.5/1. Average age was 42.0 years. Simple fractures (no intermediate fragments) are most common with 65.8% of patients. Middle third fractures accounted for 92.1% of patients. Bone union rate was 100%. The surgical results were excellent in 94.7% and good in 5.3% of cases according to Constant Score. Conclusion: Open reduction internal fi xation of clavicle fractures had good results. All patients were satisfi ed with the results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.